medibeacon-solution-banner

News

MediBeacon Presents Gastrointestinal Permeability Research

(CHICAGO – May 6, 2017) – Dr. Richard B. Dorshow, Ph.D., Chief Scientific Officer of MediBeacon and Phillip I. Tarr MD, Director of the Division of Pediatric Gastroenterology, Hepatology and Nutrition at the Washington University School of Medicine and St. Louis Children’s Hospital presented the results of initial research focused on the measurement of gut … read more

MediBeacon™ Inc. Completes Successful Clinical Study of Transdermal Glomerular Filtration Rate Monitor on Impaired Kidney Function Subjects

Expanded Multicenter Study in U.S. and Europe to Begin Fourth Quarter 2017 (SAINT LOUIS, MO, March 2, 2017) – MediBeacon Inc., a portfolio company within the Pansend Life Sciences platform of HC2 Holdings, Inc. (NYSE MKT: HCHC), announced today the successful completion of a real-time, point of care renal function clinical study on subjects with … read more

MediBeacon Presents Multiple Papers at SPIE Photonics West

Transdermal Fluorescent Detection Technology for Use in Nephrology Advances (SAN FRANCISCO, January 30, 2017) – Three papers related to continued advances in the use of transdermal fluorescent detection technology to measure and monitor Glomerular Filtration Rate (GFR) were presented at BIOS 2017. The following papers were all presented in a session chaired by MediBeacon Chief … read more

Gates Foundation Awards $1.1 Million Grant for MediBeacon™ Collaboration with Washington University

MediBeacon Inc. Collaborates with Washington University in $1.1 Million Grant for Groundbreaking Research in Global Health and Development (SAINT LOUIS, MO, October 18, 2016) – MediBeacon Inc. announced today that it would collaborate with scientists at Washington University School of Medicine in St. Louis in a research project aimed at improving the understanding of childhood … read more

National Institutes of Health Awards SBIR Grant to MediBeacon™ Inc.

NIH Grant to Support Research on MediBeacon Fluorescent Tracer Agent Use in Ocular Angiography (SAINT LOUIS, MO, August 8, 2016) – MediBeacon announced today that it is the recipient of a Small Business Innovation Research (SBIR) grant supported by the National Eye Institute (NEI) of the National Institutes of Health (NIH) under Award Number R43EY027207. … read more

MediBeacon™ Inc. Chief Executive Officer Speaks with Entrepreneur Quarterly

Founder Series Interview with Steven Hanley (SAINT LOUIS, MO, July 7, 2016) – Mr. Steven J. Hanley, Chief Executive Officer and co-founder of MediBeacon spoke with Entrepreneur Quarterly (EQ), a publication focused on promoting stories of innovation in St. Louis. Mr. Hanley sat down with EQ to share how he was drawn to working in … read more

MediBeacon™ Inc. Acquires Mannheim Pharma & Diagnostics

Technology enables kidney function measurement in preclinical applications (ST. LOUIS – June 8, 2016) – St. Louis-based MediBeacon™ Inc., maker of proprietary, non-invasive, real-time monitoring systems for kidney function, gastrointestinal permeability and other light-activated diagnostics, has completed the acquisition of Mannheim Pharma & Diagnostics, a life science company based in Mannheim, Germany. MediBeacon will continue … read more

OSA Biomedical Optics Conference Highlights Commercial Research

MediBeacon™ Inc. Chief Scientific Officer Participates on Three Industry Day Panels (FORT LAUDERDALE, FL, April 27, 2016) – Dr. Richard B. Dorshow, Ph.D., President, Chief Scientific Officer and co-founder of MediBeacon was invited to participate on three Industry Day panels at the Optical Society of America (OSA) Biomedical Optics Conference on April 27, 2016. The … read more

New MediBeacon Translational Research Presented at SPIE Photonics West

MediBeacon™ Inc. Presents Preliminary Research Findings on Novel Gastrointestinal Permeability Measurement Technique (SAN FRANCISCO, CA, January 30, 2016) – Dr. Richard B. Dorshow, Ph.D., President, Chief Scientific Officer and co-founder of MediBeacon presented initial findings on a novel technique employing fluorescent tracer agents to measure gastrointestinal permeability. This presentation was part of the “Reporters, Markers, … read more

MediBeacon™ Inc. Appoints Dr. Steven B. Miller to Board of Directors

(ST. LOUIS, MO – November 17, 2015) – St. Louis-based MediBeacon™ Inc., maker of a proprietary noninvasive real-time monitoring system for kidney function, today announced the appointment of Dr. Steven B. Miller as an independent director, effective immediately. Dr. Miller joins MediBeacon co-founders Steven J. Hanley and Richard B. Dorshow, Ph.D., and Pansend Life Sciences … read more

MediBeacon™ Inc. Presents Human Clinical Trial Results

(SAN DIEGO – November 5, 2015) – St. Louis-based MediBeacon™ Inc., maker of a proprietary noninvasive real-time monitoring system for kidney function, today presented the results of initial human clinical trials at the American Society of Nephrology (ASN) Kidney Week meetings. The American Society of Nephrology leads the fight against kidney disease by educating health … read more

MediBeacon featured on Fox 2 News, St. Louis

MediBeacon TM Inc., maker of a proprietary noninvasive real-time monitoring system for kidney function, was covered on St. Louis’ local affiliate, Fox 2 News. Below is a summary and link to the video segment broadcast on Wednesday, September 2, 2015. POSTED 10:27 PM, SEPTEMBER 2, 2015, BY Roche Madden, Click here to watch the full … read more

MediBeacon™ Inc. Enters into Agreement for $22.4 Million Investment to Bring Breakthrough Noninvasive Real-Time Kidney Monitoring to Market

Proprietary Optical Renal Function Monitor recently completed first human clinical trials (ST. LOUIS, MO – August 26, 2015) – St. Louis-based MediBeacon TM Inc., maker of a proprietary noninvasive real-time monitoring system for kidney function, announced it has entered into an agreement with Pansend LLC. Pansend, an indirect wholly owned subsidiary of HC2 Holdings, Inc. … read more

Washington University School of Medicine, in Collaboration with MediBeacon, Receives Grand Challenges Explorations Grant

Grand Challenges Explorations Grant For Groundbreaking Research in Global Health and Development (ST. LOUIS, June 4, 2014) – Washington University School of Medicine in St. Louis announced today that it is a Grand Challenges Explorations winner, an initiative funded by the Bill & Melinda Gates Foundation. Phillip I. Tarr MD, director of the Division of … read more

One Health Summit Highlights Emerging Technology Breakthroughs

MediBeaconTM Presents “Partnering to Improve Kidney Health” (KANSAS CITY, KS, March 10, 2014) – The 5th Annual One Health Summit was held at Sporting Park in Kansas City on March 5-6. The event featured an agenda focused on providing a deeper understanding of One Health & how emerging technologies impact people, animals, and our environment. Terence … read more

SPIE Photonics West Highlights Translational Research

MediBeaconTM Presentation Highlighted as Bench-to-Bedside Translational Research (SAN FRANCISCO, CA, February 3, 2014) – Dr. Richard B. Dorshow, Ph.D., President, Chief Scientific Officer and Founder of MediBeacon presented safety and toxicology data on the MediBeacon renal function tracer agent APC-2 at the International Biomedical Optics Symposium (BiOS 2014) on February 3, 2014 in San Diego. BiOS … read more

Venture Summit in Boston Recognizes MediBeacon

MediBeaconTM Selected as “Best Presenter” in The Life Sciences/Healthcare Track (BOSTON, MA, December 11, 2013) – The 2013 edition of The New England Venture Summit featured a number of Medical Device innovations including MediBeacon’s Optical Renal Function Monitor system. “We selected the 90 plus Top Innovator Award recipients from around the world. Each and every one … read more

Renal Business Today “Renal Function Monitoring”

Article by Dr. Dorshow is Featured in the November 2013 Issue of Renal Business Today (ST. LOUIS, November 2013) – Renal Business Today published in the November 2013 edition an article entitled “Kidney Function Monitoring: Pathway to the Future” authored by Dr. Richard B. Dorshow, Ph.D., President, Chief Scientific Officer and Founder of MediBeacon. PDF … read more

Medical Device Company MediBeacon Primed for Growth and Commercial Success at One-Year Anniversary

Company’s success moves it closer toward launching innovative kidney function monitor (ST. LOUIS, Aug. 21, 2013) – This month, as MediBeacon reaches its one-year anniversary, the St. Louis medical device company has made significant progress in developing new technology to transform renal function monitoring practices. The Optical Renal Function Monitor (ORFM) is a noninvasive, real-time … read more

MediBeacon Highlighted in Missouri Business Alert

One On One: Terence Stern, MediBeacon Vice President (ST. LOUIS, August 3, 2013) – MediBeacon LLC, Vice President Business Development, Terence Stern recently spoke with Missouri Business Alert. The text of the article follows. By Nicole Lunger August 3, 2013 9:00 am The fourth annual St. Louis County Startup Business Plan Competition — now known as … read more

City and county launch initiative to invest in — and keep — start-ups

MediBeacon is highlighted in the St. Louis BeaconTM (ST. LOUIS, June 13, 2013) – Richard Dorshow, MediBeacon Founder and Chief Scientific Officer was interviewed in a St. Louis Beacon article describing regional support that is accelerating development of promising entrepreneurial ventures. The City and county launch initiative to invest in — and keep — start-ups … read more

InvestMidwest 2013 Highlights Medical Device Innovations

MediBeaconTM Presents at 2013 InvestMidwest Venture Capital Forum (KANSAS CITY, MO, April 4, 2013) – The 2013 edition of the InvestMidwest Venture Capital Forum featured a number of Medical Device innovations including a presentation from MediBeacon. Steve Hanley presented the MediBeacon story highlighting The Company’s focus on technology that would enable real-time, point-of-care monitoring of kidney … read more

MediBeacon Participates in Launch of 2013 Startup Challenge

Edward Jones and St. Louis Economic Council Unveil Business Competition (ST. LOUIS, April 3, 2013) – MediBeacon LLC, winner of the 2012 edition of the St. Louis County Economic Council’s competition set the stage for Edward Jones and St. Louis County Economic Council to unveil the 2013 St. Louis Startup Challenge. Edward Jones and St. … read more

SPIE Photonics West Highlights Fluorescent Tracer Technology

MediBeaconTM Presents a Poster Presentation at SPIE Photonics West 2013 (SAN FRANCISCO, February 4, 2013) – Dr. Richard B. Dorshow, Ph.D., President, Chief Scientific Officer and Founder of MediBeacon presented a poster presentation at the 2013 Society of Photo-Optical Instrumentation Engineers (SPIE) Photonics West conference. The poster presentation entitled “Real-time point-of-care measurement of impaired renal function … read more

Technology Entrepreneurs Meet With Lawmakers in Jefferson City, MO

MediBeacon™ Meets with Missouri Legislators at The State Capital (ST. LOUIS, January 16, 2013) – Technology Entrepreneur Day was held today at the state capital in Jefferson City. The objective of this event is to connect leading entrepreneurs with legislators. Dialog allows company representatives to share their individual stories and highlight how the state can … read more

St. Louis Small Business Monthly “The Ones to Watch”

MediBeaconTM is Featured in the January 2013 Issue of St. Louis Small Business Monthly (ST. LOUIS, January 2013) – Steve Hanley and Dr. Richard Dorshow were featured as two of five entrepreneurs who have developed ideas that are “too good to ignore”. The St. Louis Small Business Monthly published the following, “Keep an eye on the … read more

BioSTL News Update – MediBeacon Announced as Winner St. Louis Regional Business Plan Competition

MediBeacon, a new St. Louis-based optical diagnostic company, has won the 2012 St. Louis Regional Business Plan Competition, beating out some of the most innovative small businesses in St. Louis. With the recognition, MediBeacon receives a $50,000 grant award and 90 hours of in-kind professional services to advance the first product from their portfolio – … read more

BioSTL – St. Louis startup MediBeacon launched

BioSTL fosters collaborative efforts and builds regional infrastructure to achieve St. Louis’ potential in biosciences. BioSTL issued the following News Update on August 27, 2012. MediBeacon LLC, a new St. Louis-based optical diagnostic company has announced its initial round of funding. BioSTL’s affiliate, the BioGenerator, provided business assistance and funding to MediBeacon through its i6 … read more

MediBeacon highlighted in St. Louis Business Journal, August 24, 2012

Hanley buys Mallinckrodt patents for MediBeacon Premium content from St. Louis Business Journal by Amir Kurtovic, Reporter MediBeacon Co-founders Steve Hanley (left) and Rick Dorshow (right) plan to start human kidney diagnostic trials by early 2013. Despite all of the advances in modern medicine, there is one vital organ physicians can’t monitor in real time. … read more

MediBeacon featured on NBC 5 News, St. Louis

On August 24th, 2012, Medibecon was covered on St. Louis’ local new affiliate, KSDK. During the interview they discussed Medibeacon in it’s early stages as a startup, and the future goal of commercializing 22 patents that MediBeacon had purchased previously. Click here to watch the full video. read more